Nurse Practitioner in Gwynedd, PA Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Ms. Barbara C Ladzinski, CRNP Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1325 Sumneytown Pike, Gwynedd, PA 19437 Phone: 856-751-1610 |
Ms. Kathleen Mary Boyle-giannini, CRNP Nurse Practitioner - Gerontology Medicare: Accepting Medicare Assignments Practice Location: 1120 Meetinghouse Rd, Gwynedd, PA 19436 Phone: 215-283-7077 Fax: 215-283-7056 |
News Archive
Cord Blood America addresses shareholder questions regarding its new laboratory in Las Vegas
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas in an interview of Matthew Schissler, founder and CEO, by analyst Francis Gaskins.
GNAX demonstrates new Free Health Information Exchange at HIMSS11
Global Net Access (GNAX), a leading healthcare technology infrastructure service provider unveils a new Free Health Information Exchange (HIE) today at the 2011 Annual HIMSS Conference & Exhibition. The GNAX HIE facilitates the direct electronic exchange of patient information between healthcare providers.
Donor and patient age more important in determining kidney transplant success
Infection by virus cytomegalovirus (CMV) is a common and major complication following kidney transplantation. Previous studies have related CMV infection with increased kidney transplant failure and reduced patient survival. However, a new study published in the American Journal of Physiology—Renal Physiology reports that the age of the donor and the recipient, not CMV infection, are more important factors in determining transplant success.
New research sets out alternative approach to pandemic preparedness
'Evil' scientists, deadly viruses and terrorist plots are usually the preserve of Hollywood blockbusters. But when it comes to pandemic influenza, it is the stuff of real life. As controversy about research into the H5N1 bird flu virus continues, a new paper argues for a complete overhaul of current approaches to pandemic preparedness.
Patient enrollment completed in Phase II clinical trial of bavituximab
Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer patients.
› Verified 1 days ago